Full Press Release Details
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome.
RARE
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
Key Takeaway: Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome